CEACAM5 and neoplasm: Elevated serum levels of tumor markers were observed in 53 (59.6%) patients for the CEA marker 43 (48.3%) and for CA 19-9 in 17 (19.1%) patients, of which 15 patients had both sCEA and sCA 19-9 elevated at the same time.